(NRC) National Research Corporation Porters Five Forces Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(NRC) National Research Corporation Complete Analysis Pack
A Must-Have Tool for Decision-Makers
This National Research Corporation Porter's Five Forces Analysis helps you evaluate the company’s competitive landscape, including rivalry, buyer power, supplier power, substitutes, and new entrants. The page already shows a real preview of the report content, so you can see exactly what it looks like before buying. Purchase the full version for the complete ready-to-use analysis.
Suppliers Bargaining Power
Specialized data and survey inputs
National Research Corporation relies on healthcare data feeds, survey panels, and partner integrations, so suppliers that can deliver HIPAA-safe, high-quality inputs hold some leverage. In a market with a limited pool of compliant sources, those vendors can press for better pricing or contract terms. National Research Corporation can cut this power by diversifying inputs and partners, keeping supplier pressure moderate.
Cloud and analytics infrastructure
National Research Corporation depends on cloud hosting, storage, and AI tools to run its subscription products, so suppliers can pressure pricing on scale and security. In the cloud market, AWS held about 31%, Microsoft Azure 24%, and Google Cloud 11%, which shows real vendor concentration but also heavy rivalry. That competition limits supplier power from becoming extreme, even if switching costs stay meaningful.
Integration and interoperability partners
National Research Corporation has to plug into EHRs, payer systems, and other health IT stacks, so supplier power rises when outside vendors control APIs or access rules. In 2025, the U.S. health data move toward FHIR-based interoperability kept pressure on vendors to open systems, but closed platforms still raise integration costs. Broader standards and better data exchange should keep supplier leverage in check over time.
Specialized healthcare talent
National Research Corporation depends on scarce data scientists, healthcare analysts, and compliance pros, so supplier power is real. The U.S. Bureau of Labor Statistics projects data scientist jobs to grow 36% from 2023 to 2033, which supports higher wages and tougher retention. NRC’s niche brand and mission can help pull talent in, but labor still has leverage.
- Scarce skills lift pay pressure
- Retention costs stay elevated
- Mission helps, but not enough
Security and compliance vendors
Healthcare clients demand privacy, security, and HIPAA support, so trusted security and compliance vendors can charge premium rates. IBM’s 2024 Cost of a Data Breach report put healthcare breach losses at $9.77 million on average, the highest of any industry, which raises switching risk for National Research Corporation. That leaves suppliers with moderate bargaining power.
- High compliance stakes
- Premium pricing possible
- Failure costs are severe
National Research’s Supplier Power Stays Moderate Amid Cloud and Talent Pressure
National Research Corporation’s supplier power is moderate: scarce HIPAA-safe data, cloud, interoperability, and talent all create leverage, but vendor rivalry and standards limit it. Cloud concentration stayed high in 2025, with AWS about 31%, Azure 24%, and Google Cloud 11%, while U.S. data scientist jobs are projected to grow 36% from 2023 to 2033, keeping labor pressure high.
| Supplier factor | Latest signal | Effect |
|---|---|---|
| Cloud vendors | AWS 31%, Azure 24%, Google 11% | Moderate |
| Data talent | 36% job growth, 2023-2033 | High |
What is included in the product
Detailed Word Document
Analyzes National Research Corporation’s competitive position by assessing supplier power, buyer power, rivalry, new entrants, and substitutes.
Customizable Excel Spreadsheet
A quick Porter's Five Forces snapshot for National Research Corporation—cutting through strategic noise to reveal key risks and pressures fast.
Reference Sources
Provides a traceable source trail for National Research Corporation insights, boosting credibility and helping decision-makers verify assumptions fast.
Customers Bargaining Power
Large health system buyers
Large integrated health systems, payers, and post-acute groups buy through centralized procurement, so one deal can cover many sites and users. That scale lets them push on price, service levels, and contract terms, keeping buyer power high. In NRC Health’s market, a few large enterprise customers can meaningfully shape renewal pricing and scope.
ROI-driven purchasing
Buyers have strong bargaining power because ROI is the key test: NRC tools must show better patient experience, engagement, or lower readmissions. In Medicare’s Hospital Readmissions Reduction Program, penalties can reach 3% of base payments, so hospitals want proof, not promises. If NRC cannot tie renewals to measurable gains, customer pressure rises fast and pricing power weakens.
Switching is disruptive but possible
Implementations create sticky workflows, historical data, and reporting links, so switching takes time and risk. That cuts customer bargaining power somewhat. Still, buyers can press hard at renewal if a rival offers better pricing or packaging. In SaaS, even a small price gap can move budget decisions fast.
Multi-stakeholder decision making
Multi-stakeholder buying at National Research Corporation gives customers more power. Clinical, IT, finance, and executive leaders each test the pitch, so a 4-function review usually means more comparison shopping and tighter RFP rules. That raises switching friction for National Research Corporation and pushes pricing and terms toward the buyer.
- More stakeholders, more scrutiny
- More scrutiny, stronger buyer leverage
- RFP discipline widens vendor comparison
Demand for bundled solutions
Customers want bundled healthcare analytics and engagement platforms, not separate point tools. That can help National Research Corporation if it sells broad suites, but it also gives buyers more room to push for lower prices across modules. Buyer power stays moderate to high because switching is costly, yet platform deals often hinge on discounts and contract terms.
- Integrated suites raise buyer expectations
- Module pricing can face discount pressure
- Switching costs soften but don’t remove leverage
High Buyer Power Keeps Pricing Pressure on National Research Corporation
Customer bargaining power at National Research Corporation stays high because large health systems buy centrally and compare vendors hard at renewal. Switching costs help National Research Corporation, but ROI proof is still the main test. Hospitals also face Medicare readmission penalties of up to 3%, so buyers push for lower prices and measurable results.
| Factor | Data point |
|---|---|
| Medicare penalty cap | 3% |
| Buyer review group | 4 functions |
| Power level | High |
Preview Before You Purchase
National Research Corporation Porter's Five Forces Analysis
This preview shows the exact National Research Corporation Porter’s Five Forces Analysis you’ll receive after purchase—no edits, no placeholders, and no surprises. It’s the full, professionally written document, ready for immediate download and use the moment your payment is complete. What you see here is the final version you get.
Rivalry Among Competitors
Crowded experience-management market
NRC faces intense rivalry in a crowded experience-management market, where patient-experience, employee-engagement, and healthcare analytics vendors all chase the same health system budgets. The field is fragmented, but buyers can compare tools fast, so price and proof matter. That keeps switching pressure high and makes contract wins harder and more costly.
Strong incumbents and brands
Strong rivals like Press Ganey and Qualtrics have broad enterprise reach, so brand and scale raise the pressure on National Research Corporation. Press Ganey spans healthcare experience, while Qualtrics brought in about $1.46 billion in 2024 revenue, showing the size of the field. National Research Corporation must win by staying more healthcare-specific and delivering better service.
Feature convergence
Survey, dashboarding, and analytics are now close to table stakes, so National Research Corporation faces harder price pressure as features converge. In a market where the global customer experience software base topped $12 billion in 2025, buyers can swap vendors faster, and implementation support often matters as much as the product itself. That shifts rivalry toward tighter pricing and sharper selling.
Renewal battles
Renewal battles are a core risk for National Research Corporation because subscription revenue must be renewed year after year, not just sold once. That keeps rivals focused on the renewal date, so NRC has to prove better client outcomes, faster issue fixes, and clear ROI to defend each account.
- Renewals drive retention
- Competitors target contract end dates
- Outcome proof cuts churn risk
Consolidation and alliances
Mergers and alliances in patient-experience software can quickly reset the field around National Research Corporation. Larger platforms can bundle survey, analytics, and engagement tools, then cross-sell into National Research Corporation accounts, which lifts rivalry and raises switching pressure. In a market where scale improves sales reach and product breadth, share is harder to defend.
- Bundling widens competitive pressure
- Cross-sell risk rises for accounts
- Scale makes defense tougher
High Rivalry Puts NRC Under Price and Proof Pressure
Competitive rivalry is high for National Research Corporation because buyers can compare vendors fast, and renewal cycles keep pressure on each account. Press Ganey and Qualtrics raise the bar on scale and breadth, while feature overlap makes price and proof matter more. NRC wins by staying healthcare-specific and showing clear ROI.
| Peer | Latest data | Rivalry impact |
|---|---|---|
| Qualtrics | 2024 revenue: $1.46 billion | Sets scale benchmark |
| Global CX software | Base topped $12 billion in 2025 | Intensifies price pressure |
Substitutes Threaten
In-house analytics teams
Large health systems can build in-house survey, dashboard, and reporting tools, and that is a real substitute for National Research Corporation. With more than 6,000 U.S. hospitals, many buyers have enough scale to support internal analytics teams; once built, these teams can be tailored to local workflows and often cost less per member over time. Still, NRC can win on speed, benchmarks, and lower execution risk.
Generic BI and CRM tools
Tableau, Power BI, and Salesforce can cover basic reporting and workflow needs that overlap with National Research Corporation use cases. Microsoft posted $281.7 billion in fiscal 2025 revenue, and Salesforce reported $37.9 billion, so these platforms have the scale to keep improving fast. They still lack healthcare depth, but they can replace lower-complexity NRC needs.
Public and payer data sources
Public and payer data sources are a real substitute for National Research Corporation because CMS measures, public quality scores, and claims analytics give many buyers a usable baseline. CMS covers very large populations across Medicare and Medicaid, so the data is broad even if it is not as deep as proprietary insight. That makes these weaker substitutes, but still meaningful, especially when buyers want to cut spend on paid intelligence.
Point solutions and consultants
Hospitals can buy niche tools or hire consultants for one task, like survey design or transition management, instead of paying for a full platform. With about 6,000 U.S. hospitals, even a small shift to point fixes can pull demand away from National Research Corporation and fragment revenue.
- One need, not full subscription
- Smaller spend, faster adoption
Direct feedback channels
Direct feedback channels are a real substitute because simple forms, portals, and HR tools can collect patient and employee input at near-zero marginal cost. They lack National Research Corporation’s deeper analytics and workflow support, but for basic pulse checks they are good enough, so pricing power weakens in standard survey use cases. This pressure is strongest in small sites and low-complexity programs.
- Low-cost input collection
- Good enough for simple needs
- Weakens pricing in basic segments
Moderate Substitution Risk Pressures National Research Corp
Threat of substitutes for National Research Corporation is moderate: large health systems can build internal tools, while Microsoft and Salesforce keep making generic analytics cheaper and stronger. CMS public data and niche consultants also cover lower-end needs, so buyers can cut spend when they only need basic feedback or reports.
| Substitute | Latest scale | Impact |
|---|---|---|
| Microsoft | $281.7B FY2025 revenue | Broad BI tools |
| Salesforce | $37.9B FY2025 revenue | Workflow overlap |
Entrants Threaten
SaaS lowers entry barriers
SaaS lowers entry barriers because cloud tools let startups launch survey and analytics software fast, without owning servers or other heavy assets. That makes National Research Corporation exposed to more niche rivals than a traditional data-services business. In 2024, public cloud spending was still rising fast, and that cheap access keeps new entrant risk elevated.
Trust and compliance hurdles
Healthcare buyers expect privacy, security, and proven uptime, so new entrants face long vendor reviews. In 2024, U.S. health data breaches hit more than 275 million records, which pushed compliance scrutiny even higher. That means audits, legal checks, and reference calls can delay enterprise wins by months, slowing market entry for National Research Corporation rivals.
Integration complexity
Integration is a real barrier for new entrants because linking to EHRs, payers, and operational systems takes deep technical work and constant upkeep. U.S. hospitals now rely on near-universal EHR use, so a new firm must normalize messy data and keep many interfaces stable at scale. That raises costs, slows rollout, and helps National Research Corporation keep its edge.
Brand and switching costs
Healthcare clients usually stay with National Research Corporation because they value a long track record, steady support, and trusted handling of sensitive patient data. Once historical survey data and embedded workflows are in place, switching costs rise fast, so new entrants face only moderate pressure.
- Trust and support matter most.
- Data and workflows lock in users.
- Switching stays costly and slow.
AI startups create niche risk
AI-native startups raise National Research Corporation’s entrant threat by targeting narrow, high-value workflows with lower-cost software. They may not match National Research Corporation’s full platform, but they can win a single department or module, which makes switching easier and pricing pressure sharper. The threat looks moderate over the long run.
- Lower-cost niche tools
- Module-by-module attacks
- Moderate long-term threat
Moderate Entry Barriers Keep New Rivals in Check
Threat of new entrants for National Research Corporation stays moderate. Cloud software, EHR APIs, and AI tools lower startup costs, but healthcare buyers still demand HIPAA-grade security, long vendor reviews, and integration depth. Switching costs also stay high once survey data and workflows are embedded.
| Factor | Latest data |
|---|---|
| Cloud spending | 2024 kept rising |
| Health records breached | 275M+ in 2024 |
| EHR adoption | Near-universal in U.S. hospitals |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.